Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDC25A | P30304 | 4/20 | 0.76 |
| ▸ | POLA1 | P09884 | 1/20 | 0.76 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.66 |
| ▸ | INPP5D | Q92835 | 1/20 | 0.65 |
| ▸ | ST6GAL1 | P15907 | 2/20 | 0.61 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.60 |
| ▸ | VDR | P11473 | 3/20 | 0.56 |
| ▸ | USP2 | O75604 | 1/20 | 0.56 |
| ▸ | HPSE | Q9Y251 | 4/20 | 0.55 |
| ▸ | FGF1 | P05230 | 3/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | FGF2 | P09038 | 2/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4739096 | 0.91 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL12086538 | 0.91 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL15113084 | 0.91 | CDC25A (0.74) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19009189 | 0.90 | CDC25A (0.76) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL875595 | 0.90 | CDC25A (0.76) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL17123434 | 0.90 | CDC25A (0.76) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19009194 | 0.90 | CDC25A (0.73) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL23813359 | 0.90 | CDC25A (0.78) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL4735227 | 0.90 | CDC25A (0.78) | CDC25APOLA1CYP2D6CYP2C19INPP5D | |
| SCHEMBL19184920 | 0.90 | CDC25A (0.78) | CDC25APOLA1CYP2D6CYP2C19INPP5D |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112386504-A | Dispersible powder and cosmetic | 信越化学工业株式会社 | 2021-02-23 | — | — | CN | claimed |
| US-20210045990-A1 | DISPERSIBLE POWDER AND COSMETIC | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2021-02-18 | — | — | US | claimed |
| EP-3777818-A1 | DISPERSIBLE POWDER AND COSMETIC | Shin-Etsu Chemical Co., Ltd. (JP) | 2021-02-17 | — | — | EP | claimed |
| EP-2123259-A1 | LIPOSOME PREPARATION FOR IONTOPHORESIS HAVING ANTIOXIDANT COMPONENT ENCAPSULATED THEREIN | Hokkaido University (JP) | 2009-11-25 | — | — | EP | claimed |
| EP-2098221-A1 | COMPOSITION FOR IONTOPHORESIS FOR DELIVERY THROUGH HAIR PORE | Hokkaido University (JP) | 2009-09-09 | — | — | EP | claimed |
| US-20090022784-A1 | SYSTEMS, DEVICES, AND METHODS FOR IONTOPHORETIC DELIVERY OF COMPOSITIONS INCLUDING LIPOSOME-ENCAPSULATED INSULIN | NATIONAL UNIVERSITY CORPORATION HOKKAIDO UNIVERSITY (JP) | 2009-01-22 | — | — | US | claimed |
| US-20080193514-A1 | COMPOSTIONS AND METHODS FOR IONTOPHORESIS DELIVERY OF ACTIVE INGREDIENTS THROUGH HAIR FOLLICLES | TRANSCU LTD. (SG) | 2008-08-14 | — | — | US | claimed |
| US-20080175895-A1 | SYSTEM, DEVICES, AND METHODS FOR IONTOPHORETIC DELIVERY OF COMPOSITIONS INCLUDING ANTIOXIDANTS ENCAPSULATED IN LIPOSOMES | KOGURE KENTARO | 2008-07-24 | — | — | US | claimed |
| CN-1319510-C | Liquid cosmetic | KOSE CO LTD (JP) | 2007-06-06 | — | — | CN | claimed |
| US-5162377-A | Cosmetics, Drugs | SHISEIDO COMPANY, LTD. (JP) | 1992-11-10 | — | — | US | claimed |
| JP-4243806-A | — | — | None | — | — | JP | disclosed |
| CN-118354757-A | Oil gelling agent and cosmetic | 信越化学工业株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-12029303-B2 | Method for preparation of a cosmetic kit | SHISEIDO COMPANY, LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| WO-2024135300-A1 | COSMETIC COMPOSITION, COSMETIC COMPOSITION FOR SUPPRESSING DISCOLORATION, AND DISCOLORATION SUPPRESSANT | 株式会社資生堂 | 2024-06-27 | — | — | WO | disclosed |
| EP-3449904-B1 | EMULSIFIED COSMETIC | SHINETSU CHEMICAL CO (JP) | 2024-06-19 | — | — | EP | disclosed |
| US-5162377-A | Cosmetics, Drugs | SHISEIDO COMPANY, LTD. (JP) | 1992-11-10 | — | — | US | disclosed |
| JP-H04243806-A | TWO LAYER TYPE COSMETIC CONTAINING LIQUID CRYSTAL | MIKIMOTO PHARMACEUT CO LTD | 1992-08-31 | — | — | JP | disclosed |
| US-4897261-A | ORGANIC SOLVENTS, OIL AND WATER SOLUBLE POLYMERS,MOISTURIZERS, HYDROPHILIC AND LIPOPHILIC COMPONENTS | SHISEIDO COMPANY LTD. (JP) | 1990-01-30 | — | — | US | disclosed |
| EP-0349150-A2 | Transparent compostition | SHISEIDO COMPANY LIMITED (JP) | 1990-01-03 | — | — | EP | disclosed |
| EP-0291555-A1 | Fingernail cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 1988-11-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210045990-A1 | DISPERSIBLE POWDER AND COSMETIC | PHOSPHO1, CUTA, PLD1 | CDC25A 613/4885POLA1 1844/4885CYP2D6 4509/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.